Clinical trial
Perceived Hypoglycemia- and Weight-related Quality of Life of Patients With Sulfonylurea Derivate-treated Diabetes Mellitus Type 2, a Non-interventional Study.
NCT01244646 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perceived Hypoglycemia- and Weight-related Quality of Life of Patients With Sulfonylurea Derivate-treated Diabetes Mellitus Type 2, a Non-interventional Study.
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 48 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus type 2